Tender detail
Non-exclusive discount agreements for ranibizumab medicines under an open-house model
Summary
The procurement concerns non-exclusive discount agreements for medicines containing ranibizumab, supplied as a 10 mg/ml solution for injection in pre-filled syringes (ATC code S01LA04). The agreements are concluded under an open-house model, with no guaranteed minimum purchase volume; actual demand is unknown. Agreements end no later than 31 December 2027, although the procedure may end earlier.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.